The authors explain waivers and deferrals for pediatric studies of drugs and biologics as provided by the Pediatric Research Equity Act of 2007. The Pediatric Research Equity Act of 2007 (PREA), ...
Changes in the regulatory environment in the United States and European Union have the potential to advance the concept of precision medicine to children with cancer. Preclinical testing of targeted ...
Please provide your email address to receive an email when new articles are posted on . The Research to Accelerate Cures and Equity Act led to an increase in required pediatric studies for recently ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback